Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesamorelin for HIV-associated abdominal fat accumulation
NCT00608023Phase 3Completed
- Sponsor
- Theratechnologies Inc.
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- Peptides
- Countries
- 6
01
Overview
A Phase 3 trial of tesamorelin in HIV-associated lipodystrophy (HALS), sponsored by Theratechnologies Inc.. Started Aug 2007; status: completed.
02
Drugs
tesamorelin
03
Conditions
HIV-associated lipodystrophy (HALS)
Beyond the preview
Go deeper on NCT00608023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608023.